3//SEC Filing
RedCo II Master Fund, L.P. 3
Accession 0001104659-23-056206
CIK 0001769804other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 9:30 PM ET
Size
6.6 KB
Accession
0001104659-23-056206
Insider Transaction Report
Form 3
Augmedix, Inc.AUGX
RedCo II Master Fund, L.P.
Director10% Owner
Holdings
- 8,696,146
Common Stock
Pre-Funded Warrants to Purchase Common Stock
Exercise: $0.00From: 2023-04-19→ Common Stock (3,125,195 underlying)
Footnotes (3)
- [F1]Redmile Group, LLC ("Redmile") has filed a Form 4 concurrently with RedCo II Master Fund, L.P.'s ("RedCo II") filing of this Form 3 to report Redmile's indirect beneficial ownership of the Common Stock.
- [F2]The Pre-Funded Warrants are exercisable by the holder at any time on or after the date of the securities purchase agreement between Augmedix, Inc. (the "Issuer") and certain stockholders, including RedCo II Master Fund, L.P., dated as of April 19, 2023, until fully exercised at an exercise price of $0.0001 per Pre-Funded Warrant share, subject to a limitation on the right of the Issuer to issue the Pre-Funded Warrant shares if and to the extent that such exercise would violate the rules or regulations of Nasdaq Stock Market LLC. The Pre-Funded Warrants have no expiration date.
- [F3]Redmile filed a Form 4 on April 21, 2023 to report its indirect beneficial ownership of the Pre-Funded Warrants.
Documents
Issuer
Augmedix, Inc.
CIK 0001769804
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001921783
Filing Metadata
- Form type
- 3
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 9:30 PM ET
- Size
- 6.6 KB